On Tuesday, Nov. 5, as part of the Johns Hopkins Medicine’s Department of Neurology and Neurosurgery Neuroimmunology Seminar Series, Dr. Amber Salter delivered an overview of her ongoing work ...

The researchers utilized a Fra-2 transgenic mouse model that encompasses many of the features of systemic sclerosis in humans, including spontaneous systemic inflammation and fibrosis in the lungs, ...

The results from a new study of the multi-kinase inhibitor fexagratinib in mouse models are raising hopes that the therapy ...

The California biotech has drawn partnerships with Eli Lilly and J&J on the promise of its approach to rebalancing the immune ...

Lupus is an 'uncommon, complex, and poorly understood disease' and GPs may not recognise the early warning signs, according ...

Zura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults with Systemic Sclerosis ...

The Mass General Brigham Gene and Cell Therapy Institute, a hub of innovation dedicated to accelerating groundbreaking research, conducting clinical trials and developing FDA-approved treatments, ...

EBR Systems is among ASX healthcare stocks with upcoming catalysts, expecting feedback on a FDA substantive review expected ...

Recent research suggests that one surprising nutrient may be the key to improving general health and slashing diabetes risk.

But those kinds of risk factors aren’t enough on their own. People have to be exposed to one or more “triggers” that tip the ...

Millions of people across the UK suffering from certain health conditions can get up to £5,740 a year from the Department for ...

Charles Foster believes he has a duty to defend against a state-sanctioned and medicalised means to self-obliterate ...